Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × fasudil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostate CA 1 Ovarian Neoplasms 1 Lymphoma, Follicular 1 Cognitive Dysfunction 1 Alzheimer Disease 1

Interventions

Exercise 6 Transcranial Direct Current Stimulation 4 Neuropsychological Tests 4 Walking 3 Memantine 3 Tablets 2 Standard of Care 2 Patient Reported Outcome Measures 2 Methods 2 Electroencephalography 2 Drug Therapy 2 Donepezil 2 Cognitive Behavioral Therapy 2 mazdutide 1 lithium sulfate 1 lime 1 fasudil 1 enzalutamide 1 blueberry extract 1 beta Carotene 1 acetaminophen, aspirin, caffeine drug combination 1 XENP 1595 1 Waiting Lists 1 Vitamin E 1 Vitamin D 1 Ultraviolet Therapy 1 Transcranial Magnetic Stimulation 1 Time 1 Therapeutics 1 Tai Ji 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06362707 2024-10-22

FEAD

Helse Stavanger HF

Phase 2 Recruiting

Alzheimer Disease, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡